Utilization of Ketamine for Major Depression

Major depressive disorder (MDD) continues to be a prevalent disease worldwide. While selective serotonin reuptake inhibitors and other medications continue prescribed, further research has been conducted toward treatment modalities. Within the past decade, ketamine, an N-methyl-d-aspartate receptor antagonist, extensively studied as new for MDD. Recent studies show that ketamine at subanesthetic doses provides antidepressant effects. An extensive overview of latest statistics MDD plans are emphasized, with review current their subsequent side However, important factor consider is dissociation, given ketamine’s psychotomimetic effects, it must reviewed further. Despite such effects hallucinations depersonalization, have shown administration achieves rapid lasting synergistic also analyzed recent summarize different A summary possible provided. By focusing on evolution MDD, physicians can now utilize newer techniques depression, better short-term long-term outcomes patients.